En esta página
01RIGL precio
02Instantánea
03Gráfico
04Divisiones de acciones
06Rendimiento
07Valoración y ratios
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
23Noticias
26Mis Métricas
RIGL Rigel Pharmaceuticals, Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 4, 2026
$47,15
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$24,95mínimo 52 semanas
$52,24máximo 52 semanas
Capitalización Bursátil
$863M
P/E (TTM)
2.8
BPA (TTM)
$16.89
Ingresos (TTM)
$277M
tus insignias
Rango 52S
$25–$52
Calificación del Analista
STRONG BUY
Precio Objetivo
$63
P/E
2.8
ROE
126.9%
Margen de Beneficio Neto
116.3%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
RIGL Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$47.15
Capitalización Bursátil
$863M
P/E (TTM)
2.8
BPA (TTM)
$16.89
Ingresos (TTM)
$277M
ROE (TTM)
126.9%
Rango 52S
$25–$52
RIGL Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Divisiones de acciones
| Fecha ex-dividendo | División | Tipo |
|---|---|---|
| 27 de junio de 2024 | 1-for-10 | Inversa |
| 25 de junio de 2003 | 1-for-9 | Inversa |
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$294M2016-12-31 → 2025-12-31
BPA$19.482019-12-31 → 2025-12-31
Flujo de caja libre·2016-12-31 → 2022-12-31
Margen neto116.3%2018-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | RIGL | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | 2.8promedio 5A ≈-47.2 | ≈-47.2 | · | · | |
| P/S | 2.9promedio 5A ≈15.6 | ≈15.6 | 12.6 | Infravalorado | |
| P/B (P/C) | 2.2promedio 5A ≈-7.4 | ≈-7.4 | 4.6 | Infravalorado | |
| Price / Cash Flow (Precio / Flujo de Caja) | 11.4promedio 5A ≈63.4 | ≈63.4 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 2.4 | · | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | RIGL | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Margen Operativo (TTM) | 31.5%promedio 5A ≈-3.2% | ≈-3.2% | -180.0% | De primer nivel | |
| Margen EBITDA (TTM) | 32.4%promedio 5A ≈-2.2% | ≈-2.2% | -180.0% | De primer nivel | |
| Margen antes de impuestos (TTM) | 30.9%promedio 5A ≈-6.0% | ≈-6.0% | -170.5% | De primer nivel | |
| Margen de Beneficio Neto (TTM) | 116.3%promedio 5A ≈10.5% | ≈10.5% | -170.6% | De primer nivel | |
| ROA (TTM) | 88.5%promedio 5A ≈9.8% | ≈9.8% | -39.1% | De primer nivel | |
| ROE (TTM) | 126.9%promedio 5A ≈47.1% | ≈47.1% | -50.7% | De primer nivel | |
| ROIC | 96.5%promedio 5A ≈251.5% | ≈251.5% | -59.1% | De primer nivel |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | RIGL | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 1.9promedio 5A ≈2.1 | ≈2.1 | 11.7 | Baja liquidez | |
| Ratio Rápido (MRQ) | 1.6promedio 5A ≈1.9 | ≈1.9 | 4.9 | Por debajo del promedio |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | RIGL | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | 64.1%promedio 5A ≈26.5% | ≈26.5% | · | · | |
| Revenue CAGR 3Y (Ingresos CAGR 3A) | 34.8%promedio 5A ≈14.5% | ≈14.5% | · | · | |
| Revenue CAGR 5Y (Ingresos CAGR 5A) | 22.1% | · | · | · | |
| EPS YoY (EPS interanual) | 1867.7% | · | · | · | |
| Net Income YoY (Beneficio Neto interanual) | 1999.1% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | RIGL | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.9promedio 5A ≈1.0 | ≈1.0 | 0.5 | De primer nivel | |
| Inventory Turnover (Rotación de Inventario) | 2.2promedio 5A ≈1.4 | ≈1.4 | · | · | |
| Receivables Turnover (Rotación de Cuentas por Cobrar) | 6.3promedio 5A ≈5.7 | ≈5.7 | · | · | |
| Revenue / Employee (Ingresos / Empleado) | ≈$1.7M | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
111.8%
Próximo informe
Nov 02, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 3, 2026 | $0.88 | $0.63 | 39.2% |
| 31 de marzo de 2026 | $0.44 | $0.78 | -43.2% | |
| 31 de diciembre de 2025 | $1.15 | $1.27 | -9.6% | |
| 30 de septiembre de 2025 | $1.46 | $0.87 | 67.5% | |
| 30 de junio de 2025 | $3.28 | $2.63 | 24.6% | |
| 31 de marzo de 2025 | $0.63 | $0.09 | 592.3% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $294M | $179M | $117M | $120M | $149M | $109M | $59M | $45M | $4M | $20M | |
| Cost of Revenue | $20M | $19M | $7M | $2M | $1M | $895.0K | $906.0K | $287.0K | · | · | |
| R&D Expense | $33M | $23M | $25M | · | · | · | · | · | · | · | |
| SG&A Expense | $116M | $113M | $106M | $112M | $92M | $77M | $75M | $70M | $38M | $21M | |
| Operating Expenses | $169M | $155M | $137M | $176M | $162M | $138M | $128M | $117M | $84M | $90M | |
| Operating Income | $125M | $24M | $-20M | $-56M | $-12M | $-29M | $-69M | $-73M | $-80M | $-70M | |
| Interest Expense | · | $8M | $7M | $4M | $5M | $1M | $335.0K | · | · | · | |
| Interest Income | $4M | $2M | $2M | $684.0K | $47.0K | $582.0K | $3M | $2M | $892.0K | $437.0K | |
| Pretax Income | $122M | $18M | $-25M | $-59M | $-17M | $-30M | $-67M | · | · | · | |
| Income Tax | $-245M | $881.0K | $0 | · | $605.0K | · | · | $0 | $0 | $0 | |
| Net Income | $367M | $17M | $-25M | $-59M | $-18M | $-30M | $-67M | $-70M | $-78M | $-69M | |
| EPS (Basic) | $20.40 | $0.99 | $-1.44 | $-3.44 | $-0.11 | $-0.18 | $-0.40 | · | · | · | |
| EPS (Diluted) | $19.48 | $0.99 | $-1.44 | $-3.44 | $-0.11 | $-0.18 | $-0.40 | · | · | · | |
| Shares (Basic) | 17,987,000 | 17,579,000 | 17,401,000 | 17,049,000 | 170,492,000 | 168,754,000 | 167,400,000 | · | · | · | |
| Shares (Diluted) | 18,840,000 | 17,687,000 | 17,401,000 | 17,049,000 | 170,492,000 | 168,754,000 | 167,400,000 | · | · | · | |
| EBITDA | $128M | $26M | $-19M | $-55M | $-11M | $-28M | $-68M | $-72M | · | $-69M |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $41M | $57M | $33M | $24M | $19M | $30M | $23M | $76M | $38M | $18M | |
| Short-term Investments | $114M | $21M | $24M | $34M | $106M | $27M | $76M | $52M | $77M | $57M | |
| Receivables | $52M | $42M | $31M | $40M | $15M | $16M | $10M | $4M | $0 | $0 | |
| Inventory | $12M | $6M | $6M | $9M | $7M | $2M | $1M | $894.0K | · | · | |
| Prepaid Expense | $22M | $10M | $6M | $8M | $7M | $14M | $9M | $3M | $2M | $1M | |
| Other Current Assets | $5M | $5M | · | · | · | · | · | · | · | · | |
| Current Assets | $240M | $135M | $99M | $116M | $154M | $89M | $119M | $137M | $117M | $76M | |
| PP&E (Net) | $30.0K | $92.0K | $165.0K | $857.0K | $2M | $3M | $2M | $1M | $875.0K | $1M | |
| PP&E (Gross) | $347.0K | $353.0K | $2M | $12M | $17M | $16M | $15M | $14M | $13M | $20M | |
| Accum. Depreciation | $317.0K | $261.0K | $2M | $11M | $15M | $14M | $13M | $13M | $12M | $19M | |
| Intangibles | $25M | $27M | $14M | $15M | · | · | · | · | · | · | |
| Other Non-current Assets | $2M | $2M | $3M | $640.0K | $974.0K | $824.0K | $696.0K | $735.0K | $803.0K | $764.0K | |
| Total Assets | $514M | $164M | $117M | $134M | $167M | $110M | $148M | $139M | $119M | $78M | |
| Accounts Payable | $7M | $3M | $7M | $23M | $4M | $4M | $4M | $6M | $3M | $6M | |
| Accrued Liabilities | · | · | · | · | $4M | $4M | $3M | · | · | · | |
| Current Liabilities | $99M | $63M | $53M | $65M | $64M | $41M | $58M | $28M | $18M | $23M | |
| Capital Leases | $395.0K | $0 | $285.0K | $972.0K | $759.0K | $11M | $19M | · | · | · | |
| Other Non-current Liabilities | $0 | $40M | $40M | $42M | $53M | $5M | $5M | · | $38.0K | $2.0K | |
| Total Liabilities | $122M | $161M | $146M | $148M | $137M | · | · | · | · | · | |
| Long-term Debt | $52M | $60M | $60M | $40M | $20M | $20M | $10M | · | · | · | |
| Common Stock | $18.0K | $18.0K | $17.0K | $174.0K | $172.0K | $169.0K | $168.0K | $167.0K | $147.0K | $100.0K | |
| Retained Earnings | $-1.02B | $-1.39B | $-1.41B | $-1.38B | $-1.32B | $-1.31B | $-1.28B | $-1.21B | $-1.14B | $-1.06B | |
| AOCI | $181.0K | $10.0K | $8.0K | $-153.0K | $-102.0K | $-4.0K | $23.0K | $-24.0K | $-82.0K | $-18.0K | |
| Stockholders' Equity | $391M | $3M | $-29M | $-14M | $30M | $34M | $54M | $110M | $101M | $55M | |
| Liabilities + Equity | $514M | $164M | $117M | $134M | $167M | $110M | $148M | $139M | $119M | $78M | |
| Shares Outstanding | 18,310,934 | 17,710,216 | 17,482,513 | 173,398,645 | 171,602,226 | 169,316,782 | 167,987,850 | 167,171,505 | 146,814,906 | 99,269,418 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $1M | $998.0K | $1M | $706.0K | $683.0K | $594.0K | $465.0K | $941.0K | |
| Stock-based Comp | $13M | $12M | $9M | $12M | $9M | $7M | $9M | $8M | $6M | $7M | |
| Deferred Tax | $-246M | $0 | $0 | · | · | · | · | · | · | · | |
| Amort. of Intangibles | $2M | $2M | $1M | $100.0K | · | · | · | · | · | · | |
| Restructuring | · | · | · | $1M | $4M | · | · | · | · | $6M | |
| Other Non-cash | $-61M | $-635.0K | $9M | $-29M | $13M | $-30M | $16M | $3M | · | · | |
| Operating Cash Flow | $76M | $31M | $-6M | $-74M | $6M | $-52M | $-42M | $-59M | $-78M | $-76M | |
| CapEx | · | · | · | $450.0K | $627.0K | $1M | $1M | $1M | $164.0K | $804.0K | |
| Investing Cash Flow | $-92M | $4M | $-4M | $73M | $-80M | $47M | $-24M | $25M | $-19M | $25M | |
| Stock Issued | · | · | · | · | · | · | · | $67M | $114M | $24M | |
| Net Stock Activity | · | · | · | · | · | · | · | $67M | · | $30M | |
| Financing Cash Flow | $601.0K | $-12M | $18M | $7M | $63M | $13M | $11M | $72M | $118M | $25M | |
| Net Change in Cash | · | · | · | · | · | · | · | $38M | $21M | $-26M | |
| Taxes Paid | $1M | $331.0K | $81.0K | · | · | · | · | · | · | · | |
| Free Cash Flow | · | · | · | $-74M | $5M | $-53M | $-43M | $-60M | · | $-77M | |
| Levered FCF | · | · | · | · | $221.1K | · | · | · | · | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 42.6% | 13.5% | -17.5% | -46.2% | -8.4% | -26.7% | -116.5% | -163.3% | · | · | |
| Net Margin | 124.7% | 9.8% | -21.5% | -48.7% | -12.0% | -27.4% | -112.8% | -158.3% | · | · | |
| Pretax Margin | 41.4% | 10.2% | -21.5% | -48.7% | -11.6% | · | · | · | · | · | |
| EBITDA Margin | 43.5% | 14.7% | -16.5% | -45.4% | -7.6% | -26.0% | -115.4% | -162.0% | · | · | |
| ROA | 108.3% | 12.4% | -20.0% | -38.8% | -12.9% | -23.1% | -46.7% | -54.6% | · | · | |
| ROE | 155.1% | -308.2% | 83.0% | 350.2% | -44.8% | -70.0% | -109.0% | -66.1% | · | · | |
| ROIC | 96.5% | 700.5% | · | · | -42.6% | · | · | · | · | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.4 | 2.1 | 1.9 | 1.8 | 2.4 | 2.2 | 2.0 | 4.9 | · | 3.4 | |
| Quick Ratio | 2.1 | 1.9 | 1.6 | 1.5 | 2.2 | 1.8 | 1.9 | 4.8 | · | 3.3 | |
| Interest Coverage | · | 3.1 | -3.0 | -15.0 | -2.6 | -21.4 | -206.2 | · | · | · |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.9 | 1.3 | 0.9 | 0.8 | 1.1 | 0.8 | 0.4 | 0.3 | · | · | |
| Inventory Turnover | 2.2 | 3.2 | 1.0 | 0.2 | 0.3 | 0.6 | 0.8 | 0.6 | · | · | |
| Receivables Turnover | 6.3 | 5.0 | 3.3 | 4.3 | 9.5 | 8.3 | 8.4 | 21.8 | · | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $21.38 | $0.19 | $-0.16 | $-0.08 | $0.18 | $0.20 | $0.32 | $0.66 | · | $0.55 | |
| Revenue / Share | $15.62 | $10.14 | $0.67 | $0.70 | $0.88 | · | · | · | · | · | |
| Cash Flow / Share | $4.02 | $1.78 | $-0.03 | $-0.43 | $0.03 | · | · | · | · | · | |
| Cash / Share | $2.22 | $3.20 | $0.19 | $0.14 | $0.11 | $0.18 | $0.13 | $0.46 | · | $0.18 | |
| EPS (TTM) | $19.48 | $0.99 | $-1.44 | $-3.44 | $-0.11 | $-0.18 | $-0.40 | · | · | · |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 64.1% | 53.4% | -2.8% | -19.4% | 37.4% | · | · | · | · | · | |
| Revenue CAGR 3Y | 34.8% | 6.3% | 2.5% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 22.1% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 1867.7% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 1999.1% | · | · | · | · | · | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $294M | $179M | $117M | $120M | $149M | $109M | $59M | $45M | $4M | $20M | |
| Net Income TTM | $367M | $17M | $-25M | $-59M | $-18M | $-30M | $-67M | $-70M | $-78M | $-69M | |
| Market Cap | $784M | $298M | $2.53B | $2.60B | $4.55B | $5.93B | $3.59B | $3.84B | · | $2.36B | |
| P/E | 2.2 | 17.0 | -10.1 | -4.4 | -240.9 | -194.4 | -53.5 | · | · | · | |
| P/S | 2.7 | 1.7 | 21.7 | 21.6 | 30.5 | 54.6 | 60.6 | 86.4 | · | 115.9 | |
| P/B | 2.0 | 90.6 | -88.5 | -191.0 | 149.7 | 174.2 | 66.8 | 35.0 | · | 42.9 | |
| P / Tangible Book | 2.1 | · | · | · | 149.7 | 174.2 | · | · | · | · | |
| P / Cash Flow | 10.4 | 9.5 | -441.4 | -35.3 | 773.6 | -113.6 | -86.6 | -65.4 | · | -31.1 | |
| P / FCF | · | · | · | -35.0 | 866.0 | -110.9 | -83.7 | -64.2 | · | -30.8 | |
| Earnings Yield | 45.5% | 5.9% | -9.9% | -22.9% | -0.42% | -0.51% | -1.9% | · | · | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $79M | $59M | $70M | $69M | $102M | $53M | $58M | $55M | $37M | $30M | $28M | $27M | $26M | $22M | $30M | $17M | |
| Cost of Revenue | $9M | $5M | $6M | $5M | $5M | $4M | $6M | $8M | $3M | $2M | $1M | $1M | $977.0K | $250.0K | $1M | $121.0K | |
| R&D Expense | $14M | $12M | · | · | $7M | $8M | · | · | · | · | · | · | · | · | · | · | |
| SG&A Expense | $33M | $31M | $30M | $29M | $29M | $28M | $30M | $27M | $28M | $28M | $25M | $26M | $28M | $26M | $27M | $27M | |
| Operating Expenses | $55M | $47M | $47M | $41M | $41M | $41M | $41M | $41M | $36M | $36M | $33M | $32M | $39M | $41M | $43M | $43M | |
| Operating Income | $24M | $12M | $23M | $28M | $61M | $13M | $17M | $14M | $447.0K | $-7M | $-4M | $-5M | $-13M | $-18M | $-13M | $-26M | |
| Interest Expense | · | · | · | $2M | $2M | $2M | · | $2M | $2M | $2M | $2M | $2M | $1M | $826.0K | $569.0K | $1M | |
| Interest Income | $789.0K | $1M | $1M | $1M | $753.0K | $591.0K | $522.0K | $425.0K | $552.0K | $593.0K | $672.0K | $529.0K | $393.0K | $192.0K | $42.0K | $21.0K | |
| Pretax Income | $24M | $12M | $23M | $28M | $60M | $12M | $15M | $12M | $-1M | $-8M | · | · | · | $-19M | $-13M | $-27M | |
| Income Tax | $6M | $3M | $-245M | $-280.0K | $369.0K | $65.0K | $881.0K | $0 | $0 | $0 | · | · | · | $0 | $0 | $0 | |
| Net Income | $17M | $9M | $268M | $28M | $60M | $11M | $14M | $12M | $-1M | $-8M | $-6M | $-7M | $-14M | $-19M | $-13M | $-27M | |
| EPS (Basic) | $0.93 | $0.47 | $14.88 | $1.55 | $3.33 | $0.64 | $0.81 | $0.71 | $-0.06 | $-0.47 | $-0.33 | $-0.38 | $-0.08 | $-0.11 | $-0.08 | $-0.16 | |
| EPS (Diluted) | $0.88 | $0.44 | $14.11 | $1.46 | $3.28 | $0.63 | $0.82 | $0.70 | $-0.06 | $-0.47 | $-0.33 | $-0.38 | $-0.08 | $-0.11 | $-0.08 | $-0.16 | |
| Shares (Basic) | 18,541,000 | 18,412,000 | · | 18,038,000 | 17,885,000 | 17,808,000 | · | 17,600,000 | 17,549,000 | 17,520,000 | 17,436,000 | 17,356,000 | 173,568,000 | 172,836,000 | 172,147,000 | 171,774,000 | |
| Shares (Diluted) | 19,570,000 | 19,686,000 | · | 19,156,000 | 18,162,000 | 18,169,000 | · | 17,648,000 | 17,549,000 | 17,520,000 | 17,436,000 | 17,356,000 | 173,568,000 | 172,836,000 | 172,147,000 | 171,774,000 | |
| EBITDA | $24M | $12M | · | $28M | $61M | $13M | · | $14M | $447.0K | $-7M | $-4M | $-5M | $-12M | $-18M | $-13M | $-26M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $61M | $24M | $41M | $49M | $53M | $46M | $57M | $52M | $36M | $26M | $45M | $49M | $40M | $30M | $27M | $25M | |
| Short-term Investments | $35M | $122M | $114M | $89M | $55M | $31M | $21M | $9M | $13M | $24M | $17M | $16M | $18M | $52M | $62M | $83M | |
| Receivables | $56M | $50M | $52M | $46M | $40M | $42M | $42M | $31M | $29M | $28M | $24M | $21M | $29M | $16M | $17M | $15M | |
| Inventory | $14M | $12M | $12M | $13M | $10M | $5M | $6M | $5M | $8M | $7M | $6M | $11M | $11M | $7M | $6M | $7M | |
| Prepaid Expense | $20M | $26M | $22M | $19M | $17M | $23M | $10M | $10M | $9M | $9M | $3M | $5M | $8M | $6M | $8M | $9M | |
| Other Current Assets | $5M | $7M | $5M | $6M | $5M | $6M | $5M | · | · | · | · | · | · | · | · | · | |
| Current Assets | $186M | $234M | $240M | $215M | $175M | $147M | $135M | $106M | $95M | $92M | $95M | $101M | $107M | $110M | $121M | $139M | |
| PP&E (Net) | · | · | $30.0K | $54.0K | $57.0K | $76.0K | $92.0K | $99.0K | $115.0K | $140.0K | $190.0K | $215.0K | $294.0K | $2M | $2M | $2M | |
| PP&E (Gross) | · | · | $347.0K | · | · | · | $353.0K | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $317.0K | · | · | · | $261.0K | · | · | · | · | · | · | · | · | · | |
| Intangibles | $94M | $24M | $25M | $25M | $26M | $27M | $27M | $28M | $28M | $29M | · | · | · | · | · | · | |
| Other Non-current Assets | $3M | $2M | $2M | $1M | $4M | $2M | $2M | $5M | $5M | $4M | $5M | $541.0K | $542.0K | $484.0K | $403.0K | $464.0K | |
| Total Assets | $521M | $505M | $514M | $243M | $207M | $176M | $164M | $139M | $128M | $127M | $115M | $117M | $124M | $116M | $128M | $149M | |
| Accounts Payable | $4M | $4M | $7M | $4M | $7M | $4M | $3M | $4M | $6M | $9M | $8M | $5M | $6M | $3M | $2M | $5M | |
| Current Liabilities | $96M | $89M | $99M | $94M | $87M | $67M | $63M | $54M | $59M | $73M | $48M | $44M | $46M | $47M | $55M | $59M | |
| Capital Leases | $58.0K | $228.0K | $395.0K | $556.0K | $714.0K | $864.0K | $0 | · | · | $100.0K | $466.0K | $628.0K | $802.0K | · | · | · | |
| Other Non-current Liabilities | · | · | $0 | · | · | $40M | $40M | $40M | $40M | $40M | $39M | $41M | $42M | $49M | $47M | $53M | |
| Total Liabilities | $96M | $105M | $122M | $125M | $125M | $157M | $161M | $154M | $158M | $158M | $147M | $145M | $148M | · | · | · | |
| Long-term Debt | · | $45M | $52M | $60M | $60M | $60M | · | $60M | $60M | $60M | $60M | $60M | $60M | $40M | $30M | $30M | |
| Common Stock | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | $17.0K | $17.0K | $175.0K | $175.0K | $175.0K | $174.0K | $173.0K | $173.0K | $172.0K | |
| Retained Earnings | $-997M | $-1.01B | $-1.02B | $-1.29B | $-1.32B | $-1.38B | $-1.39B | $-1.40B | $-1.42B | $-1.42B | $-1.41B | $-1.40B | $-1.40B | $-1.38B | $-1.36B | $-1.35B | |
| AOCI | $-148.0K | $-128.0K | $181.0K | $96.0K | $6.0K | $-2.0K | $10.0K | $11.0K | $-9.0K | $-5.0K | $-15.0K | $-25.0K | $-27.0K | $-286.0K | $-438.0K | $-416.0K | |
| Stockholders' Equity | $425M | $400M | $391M | $118M | $82M | $19M | $3M | $-15M | $-30M | $-32M | $-32M | $-28M | $-24M | $-20M | $-4M | $7M | |
| Liabilities + Equity | $521M | $505M | $514M | $243M | $207M | $176M | $164M | $139M | $128M | $127M | $115M | $117M | $124M | $116M | $128M | $149M | |
| Shares Outstanding | · | · | 18,310,934 | · | · | · | 17,710,216 | · | · | · | · | · | · | · | · | · |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $848.0K | $597.0K | $601.0K | $603.0K | $607.0K | $604.0K | $604.0K | $611.0K | $613.0K | $400.0K | $292.0K | $296.0K | $357.0K | $240.0K | $237.0K | $237.0K | |
| Stock-based Comp | $7M | $3M | $3M | $3M | $3M | $3M | $2M | $3M | $3M | $5M | $2M | $2M | $3M | $3M | $2M | $3M | |
| Amort. of Intangibles | · | $600.0K | $600.0K | $600.0K | $600.0K | $600.0K | $500.0K | $600.0K | $600.0K | $400.0K | $300.0K | $300.0K | $300.0K | · | · | · | |
| Other Non-cash | · | $-10M | · | · | · | $-16M | · | · | · | $-2M | · | · | $6M | · | · | $-2M | |
| Operating Cash Flow | $31M | $3M | $22M | $24M | $31M | $-893.0K | $15M | $22M | $302.0K | $-5M | $-1M | $6M | $-4M | $-13M | $-13M | $-26M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | · | · | $189.0K | $-36.0K | $224.0K | |
| Investing Cash Flow | $17M | $-8M | $-25M | $-33M | $-23M | $-11M | $-11M | $4M | $11M | $313.0K | $-1M | $3M | $777.0K | $10M | $21M | $23M | |
| Stock Repurchased | $511.0K | $4M | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $-4M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-12M | $-11M | $-5M | $4M | $418.0K | $484.0K | $1M | $-10M | $-752.0K | $-3M | $-869.0K | $-373.0K | $19M | $6M | $-6M | $9M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-26M | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-27M |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 29.9% | 20.2% | · | 40.9% | 60.1% | 23.9% | · | 25.4% | 1.2% | -23.6% | -15.9% | -19.6% | -48.8% | -82.1% | -43.5% | -156.9% | |
| Net Margin | 22.0% | 14.7% | · | 40.2% | 58.6% | 21.5% | · | 22.5% | -2.8% | -27.9% | -20.2% | -24.6% | -51.9% | -85.0% | -45.2% | -164.0% | |
| Pretax Margin | 30.0% | 19.8% | · | 39.8% | 59.0% | 21.6% | · | · | · | · | · | · | · | -85.0% | -45.2% | -164.0% | |
| EBITDA Margin | 29.9% | 21.2% | · | 40.9% | 60.1% | 25.1% | · | 25.4% | 1.2% | -22.2% | -15.9% | -19.6% | -47.4% | -82.1% | -43.5% | -155.5% | |
| ROA | 4.8% | 2.5% | · | 14.6% | 35.6% | 7.6% | · | 9.8% | -0.84% | -6.6% | -4.9% | -5.4% | -9.9% | -12.6% | -8.2% | -15.0% | |
| ROE | 6.8% | 4.1% | · | 54.2% | 229.2% | -174.7% | · | -53.5% | 3.5% | 29.5% | 22.0% | 41.5% | 155.1% | -127.6% | -41.9% | -64.5% | |
| ROIC | 4.1% | 2.2% | · | 24.4% | 74.1% | 68.4% | · | · | · | · | · | · | · | 92.8% | 352.6% | -386.3% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | 2.6 | · | 2.3 | 2.0 | 2.2 | · | 2.0 | 1.6 | 1.3 | 2.0 | 2.3 | 2.4 | 2.3 | 2.2 | 2.3 | |
| Quick Ratio | 1.6 | 2.2 | · | 1.9 | 1.7 | 1.8 | · | 1.7 | 1.3 | 1.1 | 1.8 | 1.9 | 1.9 | 2.1 | 1.9 | 2.1 | |
| Interest Coverage | · | · | · | 15.0 | 32.6 | 6.9 | · | 6.8 | 0.2 | -3.7 | -2.4 | -2.8 | -10.6 | -22.3 | -22.8 | -21.8 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.4 | 0.6 | 0.4 | · | 0.4 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.2 | 0.1 | |
| Inventory Turnover | 0.7 | 0.6 | · | 0.5 | 0.5 | 0.8 | · | 1.5 | 0.3 | 0.2 | 0.2 | 0.1 | 0.1 | 0.0 | 0.2 | 0.0 | |
| Receivables Turnover | 1.6 | 1.3 | · | 1.8 | 3.0 | 1.5 | · | 2.0 | 1.5 | 1.0 | 1.4 | 1.4 | 1.2 | 1.5 | 1.7 | 0.2 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $4.02 | $2.99 | · | $3.63 | $5.60 | $2.94 | · | $3.13 | $2.10 | $0.17 | $0.16 | $0.15 | $0.15 | $0.13 | $0.17 | $0.10 | |
| Cash Flow / Share | · | $0.14 | · | · | · | $-0.05 | · | · | · | $-0.03 | · | · | $-0.02 | · | · | $-0.15 | |
| EPS (TTM) | $16.89 | $19.29 | · | $6.19 | $5.43 | $2.09 | · | $-0.48 | $-1.51 | $-1.83 | $-3.88 | $-3.66 | $-3.36 | $-0.48 | $-0.49 | $-0.49 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $277M | $300M | · | $282M | $268M | $203M | · | $157M | $130M | $120M | $132M | $127M | $130M | $89M | $89M | $85M | |
| Net Income TTM | $322M | $364M | · | $113M | $98M | $37M | · | $4M | $-14M | $-20M | $-24M | $-38M | $-45M | $-83M | $-85M | $-85M | |
| P/E | 2.3 | 1.4 | · | 4.6 | 3.4 | 8.6 | · | -33.7 | -5.4 | -8.1 | -2.8 | -3.5 | -3.9 | -24.6 | -23.1 | -61.0 | |
| Earnings Yield | 43.2% | 71.3% | · | 21.9% | 29.0% | 11.6% | · | -3.0% | -18.4% | -12.4% | -35.9% | -28.4% | -25.4% | -4.1% | -4.3% | -1.6% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $294M | $179M | $117M | $120M | $149M |
| Margen Operativo % | 42.6% | 13.5% | -17.5% | -46.2% | -8.4% |
| Beneficio neto | $367M | $17M | $-25M | $-59M | $-18M |
| EPS Diluido | $19.48 | $0.99 | $-1.44 | $-3.44 | $-0.11 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 2.4 | 2.1 | 1.9 | 1.8 | 2.4 |
| Ratio Rápido | 2.1 | 1.9 | 1.6 | 1.5 | 2.2 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | · | · | · | $-74M | $5M |
Propietarios institucionales (13F) 168 declarantes · $637.8M total · A fecha de 30 de septiembre de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
168
Valor en tenencia
$637.8M
Nuevas posiciones
31
Posiciones cerradas
23
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 31 (+13 vs trimestre anterior) | 23 (-21 vs trimestre anterior) | 53 (-15 vs trimestre anterior) | 57 (+9 vs trimestre anterior) | +269K |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| BlackRock, Inc. | $75 885 690 | 1 939 818 | 11,90% | Acciones |
| Soleus Capital Management, L.P. | $72 117 876 | 1 843 504 | 11,31% | Acciones |
| ARMISTICE CAPITAL, LLC | $65 408 640 | 1 672 000 | 10,26% | Acciones |
| VANGUARD GROUP INC | $44 475 015 | 1 038 408 | 6,97% | Acciones |
| STATE STREET CORP | $40 684 565 | 1 039 994 | 6,38% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $30 713 386 | 785 107 | 4,82% | Acciones |
| AMERICAN CENTURY COMPANIES INC | $29 016 008 | 741 718 | 4,55% | Acciones |
| D. E. Shaw & Co., Inc. | $21 224 126 | 542 539 | 3,33% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $18 906 353 | 483 175 | 2,96% | Acciones |
| MARSHALL WACE, LLP | $14 372 414 | 367 393 | 2,25% | Acciones |
| CM Management, LLC | $9 780 000 | 250 000 | 1,53% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $9 143 439 | 233 728 | 1,43% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $8 917 295 | 227 951 | 1,40% | Acciones |
| GOLDMAN SACHS GROUP INC | $8 871 634 | 226 780 | 1,39% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $8 120 451 | 207 578 | 1,27% | Acciones |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $7 628 000 | 195 000 | 1,20% | Acciones |
| MORGAN STANLEY | $7 278 237 | 186 049 | 1,14% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $6 049 008 | 154 627 | 0,95% | Acciones |
| NORTHERN TRUST CORP | $5 726 425 | 146 381 | 0,90% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $5 705 496 | 145 846 | 0,89% | Acciones |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $5 131 644 | 131 177 | 0,80% | Acciones |
| AQR CAPITAL MANAGEMENT LLC | $4 882 214 | 124 801 | 0,77% | Acciones |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $4 858 078 | 124 184 | 0,76% | Acciones |
| Nuveen, LLC | $4 849 354 | 123 961 | 0,76% | Acciones |
| BANK OF AMERICA CORP /DE/ | $4 831 556 | 123 506 | 0,76% | Acciones |
| FRANKLIN RESOURCES INC | $4 825 999 | 123 364 | 0,76% | Acciones |
| UBS Group AG | $4 809 960 | 122 954 | 0,75% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $4 762 195 | 121 733 | 0,75% | Acciones |
| GLOBEFLEX CAPITAL L P | $4 407 729 | 112 672 | 0,69% | Acciones |
| CenterBook Partners LP | $4 286 574 | 109 575 | 0,67% | Acciones |
| Bank of New York Mellon Corp | $4 233 132 | 108 209 | 0,66% | Acciones |
| FMR LLC | $3 759 903 | 96 112 | 0,59% | Acciones |
| RITHOLTZ WEALTH MANAGEMENT | $3 694 884 | 94 450 | 0,58% | Acciones |
| JANUS HENDERSON GROUP PLC | $3 674 114 | 135 877 | 0,58% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $3 665 114 | 93 689 | 0,57% | Acciones |
| FIRST TRUST ADVISORS LP | $3 182 099 | 81 342 | 0,50% | Acciones |
| Empowered Funds, LLC | $3 097 678 | 79 184 | 0,49% | Acciones |
| Brandywine Global Investment Management, LLC | $3 065 343 | 71 570 | 0,48% | Acciones |
| Russell Investments Group, Ltd. | $2 973 196 | 76 002 | 0,47% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2 687 544 | 68 700 | 0,42% | Opción de compra |
| Squarepoint Ops LLC | $2 607 661 | 66 658 | 0,41% | Acciones |
| BURNEY CO/ | $2 181 683 | 55 769 | 0,34% | Acciones |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $2 159 424 | 55 200 | 0,34% | Acciones |
| WELLS FARGO & COMPANY/MN | $2 131 727 | 54 492 | 0,33% | Acciones |
| PRINCIPAL FINANCIAL GROUP INC | $2 032 088 | 51 945 | 0,32% | Acciones |
| OMERS ADMINISTRATION Corp | $2 030 328 | 51 900 | 0,32% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $1 989 800 | 50 864 | 0,31% | Acciones |
| Woodline Partners LP | $1 956 000 | 50 000 | 0,31% | Acciones |
| Connor, Clark & Lunn Investment Management Ltd. | $1 920 636 | 49 096 | 0,30% | Acciones |
| SEGALL BRYANT & HAMILL, LLC | $1 794 747 | 45 878 | 0,28% | Acciones |
Activistas y propietarios del %+ 5 5 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Persona informante no revelada, Persona informante no revelada, Persona informante no revelada | 27 de enero de 2005 | · | Presentación inicial | Inversión pasiva | SEC |
| I.R.S.Identification Nos. of above persons (entities only). FRAZIER HEALTHCARE II, L.P., I.R.S.Identification Nos. of above persons (entities only). FHM II, L.L.C., I.R.S.Identification Nos. of above persons (entities only). FRAZIER HEALTHCARE IV, L.P., I.R.S.Identification Nos. of above persons (entities only). FRAZIER AFFILIATES IV, L.P.., I.R.S.Identification Nos. of above persons (entities only). FHM IV, L.P., I.R.S.Identification Nos. of above persons (entities only). FHM IV, L.L.C., I.R.S.Identification Nos. of above persons (entities only). FRAZIER MANAGEMENT, L.L.C., I.R.S.Identification Nos. of above persons (entities only). FRAZIER & COMPANY, INC., I.R.S.Identification Nos. of above persons (entities only). ALAN D. FRAZIER | 14 de abril de 2004 | · | Presentación inicial | Inversión pasiva | SEC |
| Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada | 7 de julio de 2003 | · | Presentación inicial | Campaña de la junta directiva | SEC |
| MPM BioVentures III, L.P., MPM BioVentures III-QP, L.P., MPM BioVentures III Parallel Fund, L.P., MPM BioVentures III GmbH & Co. Beteiligungs KG, MPM Asset Management Investors 2003 BVIII, LLC, MPM BioEquities Master Fund, L.P., MPM BioVentures III GP, LP, MPM BioVentures III LLC, MPM BioEquities GP, LP, MPM BioEquities GP, LLC, Luke Evnin, Ansbert Gadicke, Nicholas Galakatos, Dennis Henner, Robert Liptak, Nick Simon, III, Michael Steinmetz, Kurt von Emster, Kurt Wheeler | 7 de julio de 2003 | · | Presentación inicial | Campaña de la junta directiva | SEC |
| MPM Bio Ventures III, L.P., MPM Bio Ventures III-QP, L.P., MPM Bio Ventures III Parallel Fund, L.P., MPM Bio Ventures III GmbH & Co. Beteiligungs KG, MPM Asset Management Investors 2003 BVIII, LLC, MPM BioEquities Master Fund, L.P., MPM Bio Ventures III GP, L.P., MPM Bio Ventures III LLC, MPM BioEquities GP, L.P., MPM BioEquities GP, LLC, Luke Evnin, Ansbert Gadicke, Nicholas Galakatos, Dennis Henner, Robert Liptak, Nicholas Simon, III, Michael Steinmetz, Kurt von Emster, Kurt Wheeler | 14 de mayo de 2003 | · | Presentación inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 41 insiders · 20 directivos · 20 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Raul R Rodriguez | CEO, President | 1 de septiembre de 2026 F | 273 362 | 0 | 0 | $0 |
| James M Gower | CEO & Board Chairman | 27 de febrero de 2014 A | 180 676 | 0 | 0 | $0 |
| Dean L Schorno | EVP & Chief Financial Officer | 2 de septiembre de 2026 M | 82 962 | 0 | 0 | $0 |
| Ryan D Maynard | EVP & CFO | 3 de noviembre de 2017 M | 0 | 0 | 0 | $0 |
| James H Welch | CFO, VP & Secretary | 25 de enero de 2006 A | 3 757 | 0 | 0 | $0 |
| David A Santos | EVP, Chief Commercial Officer | 1 de septiembre de 2026 F | 61 622 | 0 | 0 | $0 |
| Raymond J. Furey | EVP, GC, CCO & Corp Sec | 1 de septiembre de 2026 F | 50 559 | 0 | 0 | $0 |
| Alison L. Hannah | EVP, Chief Medical Officer | 8 de julio de 2026 A | 35 025 | 0 | 0 | $0 |
| Lisa Rojkjaer | EVP, Chief Medical Officer | 17 de junio de 2026 A | 34 003 | 0 | 0 | $0 |
| Wolfgang Dummer | EVP & CMO | 2 de febrero de 2023 S | 72 459 | 0 | 0 | $0 |
| Dolly Vance | EVP Corp. Affairs, G.C., Sect. | 14 de septiembre de 2022 A | 60 260 | 0 | 0 | $0 |
| Nelson Cabatuan | VP,Finance & Princ.Acctg. Off. | 14 de mayo de 2020 A | 58 | 0 | 0 | $0 |
| Eldon C. Mayer III | EVP & Chief Commercial Officer | 18 de noviembre de 2019 A | 215 000 | 0 | 0 | $0 |
| Joseph Lasaga | Sr.VP Bus.Dev.Alliance Mgmt. | 18 de noviembre de 2019 A | · | 0 | 0 | $0 |
| Esteban Masuda | Sr. VP Research | 18 de noviembre de 2019 S | · | 0 | 0 | $0 |
| Stacy Markel | EVP Human Resources | 20 de marzo de 2019 A | · | 0 | 0 | $0 |
| Anne-Marie Duliege | EVP & Chief Medical Officer | 20 de marzo de 2019 A | 0 | 0 | 0 | $0 |
| Donald G Payan | EVP, Pres. Discovery&Research | 30 de agosto de 2016 S | 53 031 | 0 | 0 | $0 |
| Elliot B Grossbard | EVP, CMO | 26 de enero de 2016 A | 2 000 | 0 | 0 | $0 |
| Robin D G Cooper | Sr. V.P. Pharmaceutical Scs. | 31 de enero de 2008 A | 9 000 | 0 | 0 | $0 |
| Kamil Ali-Jackson | Consejero | 22 de junio de 2026 S | 10 125 | 0 | 2 | $-160 425 |
| Mark W Frohlich | Consejero | 15 de mayo de 2026 A | 7 000 | 0 | 0 | $0 |
| Jane Wasman | Consejero | 15 de mayo de 2026 A | 18 250 | 0 | 0 | $0 |
| Anthony Gregg Lapointe | Consejero | 15 de mayo de 2026 A | 18 250 | 0 | 0 | $0 |
| MILLER MICHAEL PATRICK | Consejero | 15 de mayo de 2026 A | 5 937 | 0 | 0 | $0 |
| Walter H Moos | Consejero | 15 de mayo de 2026 A | 18 472 | 0 | 1 | $-145 440 |
| Brian L. Kotzin | Consejero | 25 de mayo de 2024 A | 100 000 | 0 | 0 | $0 |
| LYONS GARY A | Consejero | 26 de mayo de 2023 A | 75 000 | 0 | 0 | $0 |
| Keith Katkin | Consejero | 19 de mayo de 2021 A | 25 000 | 0 | 0 | $0 |
| Bradford S Goodwin | Consejero | 19 de mayo de 2021 A | 35 000 | 0 | 0 | $0 |
| Peter S Ringrose | Consejero | 17 de mayo de 2018 A | · | 0 | 0 | $0 |
| SHERWIN STEPHEN A | Consejero | 11 de mayo de 2016 A | · | 0 | 0 | $0 |
| Hollings Renton | Consejero | 15 de mayo de 2013 A | · | 0 | 0 | $0 |
| Jean Deleage | Consejero | 28 de mayo de 2010 A | 697 | 0 | 0 | $0 |
| Alan D Frazier | Consejero | 7 de agosto de 2006 A | 10 905 | 0 | 0 | $0 |
| Nicholas J Simon III | Consejero | 3 de junio de 2005 A | 0 | 0 | 0 | $0 |
| Dennis Henner | Consejero | 5 de enero de 2005 S | 0 | 0 | 0 | $0 |
| Michael Steinmetz | Propietario del 10% | 2 de agosto de 2004 S | 1 833 597 | 0 | 0 | $0 |
| Nicholas Galakatos | Propietario del 10% | 2 de julio de 2004 S | 1 833 597 | 0 | 0 | $0 |
| Luke Evnin | Propietario del 10% | 2 de julio de 2004 S | 1 833 597 | 0 | 0 | $0 |
| ANSBERT GADICKE | Propietario del 10% | 2 de julio de 2004 J | 0 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 31 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 1,54% | 41 313 NS | 31 de julio de 2026 | N-PORT |
| IDNA · iShares Trust | 0,82% | 44 383 SH | 11 de septiembre de 2026 | Diario |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,53% | 2 596 SH | 2 de octubre de 2026 | Diario |
| IWC · iShares Trust | 0,21% | 62 481 SH | 11 de septiembre de 2026 | Diario |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,18% | 29 124 NS | 31 de julio de 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,16% | 22 093 NS | 31 de julio de 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,13% | 23 978 SH | 19 de agosto de 2026 | Diario |
| CALF · Pacer Funds Trust | 0,09% | 84 790 NS | 31 de julio de 2026 | N-PORT |
| IBB · iShares Trust | 0,06% | 136 671 SH | 11 de septiembre de 2026 | Diario |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,06% | 1 309 SH | 2 de octubre de 2026 | Diario |
| VFMO · VANGUARD WELLINGTON FUND | 0,05% | 27 549 SH | 19 de agosto de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,05% | 15 998 SH | 19 de agosto de 2026 | Diario |
| PWS · Pacer Funds Trust | 0,05% | 302 NS | 31 de julio de 2026 | N-PORT |
| IWM · iShares Trust | 0,03% | 473 179 SH | 11 de septiembre de 2026 | Diario |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 12 438 SH | 2 de octubre de 2026 | Diario |
| RSSL · Global X Funds | 0,02% | 8 801 NS | 31 de julio de 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 105 855 SH | 19 de agosto de 2026 | Diario |
| TECB · iShares Trust | 0,02% | 1 868 SH | 11 de septiembre de 2026 | Diario |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,01% | 619 SH | 2 de octubre de 2026 | Diario |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 212 359 SH | 19 de agosto de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,01% | 54 159 SH | 19 de agosto de 2026 | Diario |
| DFAS · Dimensional ETF Trust | 0,01% | 32 659 NS | 31 de julio de 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 6 553 SH | 9 de septiembre de 2026 | Diario |
| DFAC · Dimensional ETF Trust | 0,00% | 16 178 NS | 31 de julio de 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 22 835 SH | 11 de septiembre de 2026 | Diario |
| DFAU · Dimensional ETF Trust | 0,00% | 3 010 NS | 31 de julio de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 699 NS | 31 de julio de 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 555 846 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1 629 SH | 19 de agosto de 2026 | Diario |
| DFUV · Dimensional ETF Trust | 0,00% | 112 NS | 31 de julio de 2026 | N-PORT |
| IWN · iShares Trust | · | 171 420 SH | 11 de septiembre de 2026 | Diario |
RIGL Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 11 analistas
COMPRA
Objetivo mediano
$55.00
+16,6%
4 36,4%
Compra fuerte
4 36,4%
Compra
3 27,3%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
5 analistas · 2026-09-28Objetivo medio $63.00 +33,6%
Ahora
Precio Actual $47.15
Mín$43.00
Media$63.00
Máx$85.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| RIGL | $784M | 2.2 | 64.1% | 124.7% | 155.1% | · |
| KURA | $913M | -3.3 | 25.2% | -413.0% | -116.2% | · |
| CRVS | $575M | -14.5 | · | · | -21.6% | · |
| GLUE | $1.03B | · | 63.5% | -31.2% | -15.4% | · |
| JBIO | $761M | -4.8 | · | · | -47.7% | · |
| SANA | $1.09B | -4.2 | · | · | -172.3% | · |
| OBX | · | · | · | · | · | · |
| ARDX | $1.42B | -22.4 | 22.1% | -15.1% | -40.2% | · |
| AVTX | $336M | -3.1 | -86.6% | -132642.4% | -83.4% | · |
Últimas noticias Noticias recientes que mencionan a esta empresa
¿Comprar el retroceso en Rigetti Computing, que ha caído un 66%?
Nasdaq · 4 meses, 2 semanas atrás
Rigel Pharma Firma Acuerdo de Licencia con Arvinas y Pfizer para Veppanu
Nasdaq · 4 meses, 3 semanas atrás
Rigel Pharmaceuticals Inc. Beneficio Cae En El Primer Trimestre
Nasdaq · 4 meses, 4 semanas atrás
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 4, 2026